1. Home
  2. SPT vs AMPH Comparison

SPT vs AMPH Comparison

Compare SPT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$9.91

Market Cap

553.4M

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.69

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPT
AMPH
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
553.4M
1.3B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
SPT
AMPH
Price
$9.91
$27.69
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$26.00
$35.17
AVG Volume (30 Days)
1.5M
479.9K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$443,750,000.00
$723,305,000.00
Revenue This Year
$13.14
$0.74
Revenue Next Year
$11.85
$5.63
P/E Ratio
N/A
$12.21
Revenue Growth
13.09
N/A
52 Week Low
$9.16
$20.39
52 Week High
$36.30
$46.11

Technical Indicators

Market Signals
Indicator
SPT
AMPH
Relative Strength Index (RSI) 42.89 62.39
Support Level $9.74 $24.92
Resistance Level $10.14 $27.83
Average True Range (ATR) 0.58 1.20
MACD 0.09 0.21
Stochastic Oscillator 34.40 74.94

Price Performance

Historical Comparison
SPT
AMPH

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: